Evidence map›Paper›PMID 39360592›Full record

ArticleEuropean journal of neurology2024

Cholinergic dysfunction in isolated rapid eye movement sleep behaviour disorder links to impending phenoconversion.

Miriam H Terkelsen, Alex Iranzo, Mónica Serradell, Andreas M Baun, Morten G Stokholm, Erik Hvid Danielsen, Karen Østergaard, Marit Otto, Kristina B Svendsen, Mette Møller and 10 more

Abstract read
In one paragraph

Article in European journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Miriam H TerkelsenDepartment of Nuclear Medicine and PET, Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.ORCID 0000-0003-0971-3747
Alex IranzoDepartment of Neurology, Hospital Clínic de Barcelona, Barcelona, Spain.ORCID 0000-0002-5618-8271
Mónica SerradellDepartment of Neurology, Hospital Clínic de Barcelona, Barcelona, Spain.
Andreas M BaunDepartment of Nuclear Medicine and PET, Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Morten G StokholmDepartment of Nuclear Medicine and PET, Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Erik Hvid DanielsenDepartment of Neurology, Aarhus University Hospital, Aarhus, Denmark.
Karen ØstergaardDepartment of Neurology, Aarhus University Hospital, Aarhus, Denmark.
Marit OttoDepartment of Neurology, Aarhus University Hospital, Aarhus, Denmark.
Kristina B SvendsenDepartment of Neurology, Aarhus University Hospital, Aarhus, Denmark.
Mette MøllerDepartment of Neurology, Aarhus University Hospital, Aarhus, Denmark.
Erik L JohnsenDepartment of Neurology, Aarhus University Hospital, Aarhus, Denmark.
Alicia GarridoCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain.
Dolores VilasParkinson's Disease and Movement Disorders Unit, Neurology Service, Hospital Clinic/Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Catalonia, Spain.
Joan SantamariaDepartment of Neurology, Hospital Clínic de Barcelona, Barcelona, Spain.
Arne MøllerCenter of Functionally Integrative Neuroscience, Aarhus University, Aarhus, Denmark.
Carles GaigDepartment of Neurology, Hospital Clínic de Barcelona, Barcelona, Spain.
David J BrooksDepartment of Nuclear Medicine and PET, Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Per BorghammerDepartment of Nuclear Medicine and PET, Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Eduardo TolosaCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain.
Nicola PaveseDepartment of Nuclear Medicine and PET, Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Funding

Augustinus Fonden 23-0916Danish Parkinson's Association (Parkinsonforeningen) R4-A104-B60Danmarks Frie Forskningsfond 4004-00480BDanmarks Frie Forskningsfond 8020-00260BInstituto de Salud Carlos III CB06/05/0018
6 · The paper itself

Abstract

background and purposeMost patients with isolated rapid eye movement sleep behaviour disorder (iRBD) progress to a parkinsonian alpha-synucleinopathy. However, time to phenoconversion shows great variation. The aim of this study was to investigate whether cholinergic and dopaminergic dysfunction in iRBD patients was associated with impending phenoconversion.

methodsTwenty-one polysomnography-confirmed iRBD patients underwent baseline

resultsFollow-up was accomplished in 17 patients. Eight patients progressed to either Parkinson's disease (n = 4) or dementia with Lewy bodies (n = 4), while nine remained non-phenoconverters. Compared with non-phenoconverters, 8-year phenoconverters had lower mean

conclusionsThese findings suggest that cortical cholinergic dysfunction, particularly within the parietal cortex, could be a biomarker candidate for predicting short-term phenoconversion in iRBD patients. This study aligns with previous reports suggesting dopaminergic dysfunction is associated with forthcoming phenoconversion.

Indexed as

Positron-Emission TomographyREM Sleep Behavior DisorderAgedDihydroxyphenylalanineDisease ProgressionDonepezilFemaleHumansLewy Body DiseaseMaleMiddle AgedParkinson DiseasePolysomnographyDihydroxyphenylalanineDonepezilfluorodopa F 18cholinergic neurons/abnormalitiesdopaminergic imagingpositron emission tomographyREM sleep behavior disorder

Identifiers

PMID39360592
PMCPMC11554850

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.